Human embryonic stem cells provide a potentially unlimited source of oral mucosal tissues that can revolutionize the treatment of oral diseases. These stem cells are essential to the success of novel regenerative therapies, due to their plasticity and to their tremendous regenerative potential that can overcome the shortcomings and currently limited supply of post-natal, oral epithelial stem cells. However, many obstacles still limit their therapeutic application, as it is not known if human embryonic stem cells can 1- form 3D epithelial tissues with hierarchical structure, 2 - give rise to cells similar to post-natal, epithelial stem cells or 3 - maintain their differentiated state in 3D tissues. To help overcome these barriers, the immediate goal of this application is to use our novel approaches in 3D tissue biology to provide key insights into the biological properties of human embryonic stem cells to generate 3D oral epithelial tissues that will demonstrate the feasibility of using these new technologies for future oral therapies. We hypothesize that the tissue microenvironment, instructed by basement membrane proteins and fibroblast-derived soluble factors, regulates the self-renewal and differentiation of keratinocytes derived from human embryonic stem cells to generate specialized tissues that mimic oral epithelium. To test this hypothesis, our AIMS are to: 1- Determine if keratinocytes derived from human embryonic stem cells give rise to progenitor cells with properties of post-natal stem cells that can undergo long-term, self-renewal and can differentiate to form 3D epithelia and 2- Begin to explore the cellular- and tissue-based cues, mediated by the stem cell """"""""niche"""""""" at the basement membrane interface and by fibroblast-derived soluble factors, that direct these events. We expect to set the stage for future studies that will dissect signaling pathways that direct these cues and optimize the growth, differentiation and survival of 3D epithelia. This research is made possible by two major advances in our lab: 1 - Development of engineered, 3D tissues that mimic the oral mucosa to a significant degree and have established a link between the tissue microenvironment, self- renewal of post-natal stem cells and predictable tissue regeneration after in vivo transplantation. 2 - Propagation of H9, human embryonic stem cells (NIH-WA09) committed to an epithelial lineage and generation of immature but multilayer 3D epithelial tissues from their progeny. Our long-term goal is to harness the developmental potential and growth capacity of pluripotent, human embryonic stem cells by gaining convincing evidence that oral epithelial tissues derived from them can serve as long-term, functional replacement tissues to treat oral diseases for which there are no current practical therapies. By doing so, we will advance our understanding of stem cell biology in a fundamental manner to enable future efforts to tailor and engineer lineage-specific tissues of therapeutic importance in humans. ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of Dental & Craniofacial Research (NIDCR)
Type
Research Project (R01)
Project #
1R01DE017413-01A1
Application #
7208166
Study Section
Musculoskeletal Tissue Engineering Study Section (MTE)
Program Officer
Lumelsky, Nadya L
Project Start
2007-02-05
Project End
2012-01-31
Budget Start
2007-02-05
Budget End
2008-01-31
Support Year
1
Fiscal Year
2007
Total Cost
$356,839
Indirect Cost
Name
Tufts University
Department
Dentistry
Type
Schools of Dentistry
DUNS #
039318308
City
Boston
State
MA
Country
United States
Zip Code
02111
Lucier, Rebekah N; Etienne, Olivier; Ferreira, Susana et al. (2013) Soft-tissue alterations following exposure to tooth-whitening agents. J Periodontol 84:513-9
Shamis, Yulia; Silva, Eduardo A; Hewitt, Kyle J et al. (2013) Fibroblasts derived from human pluripotent stem cells activate angiogenic responses in vitro and in vivo. PLoS One 8:e83755
Hewitt, Kyle J; Shamis, Yulia; Knight, Elana et al. (2012) PDGFR? expression and function in fibroblasts derived from pluripotent cells is linked to DNA demethylation. J Cell Sci 125:2276-87
Shamis, Yulia; Hewitt, Kyle J; Bear, Susan E et al. (2012) iPSC-derived fibroblasts demonstrate augmented production and assembly of extracellular matrix proteins. In Vitro Cell Dev Biol Anim 48:112-22
Keller, Patricia J; Arendt, Lisa M; Skibinski, Adam et al. (2012) Defining the cellular precursors to human breast cancer. Proc Natl Acad Sci U S A 109:2772-7
Alt-Holland, Addy; Sowalsky, Adam G; Szwec-Levin, Yonit et al. (2011) Suppression of E-cadherin function drives the early stages of Ras-induced squamous cell carcinoma through upregulation of FAK and Src. J Invest Dermatol 131:2306-15
Hewitt, Kyle J; Shamis, Yulia; Hayman, Ryan B et al. (2011) Epigenetic and phenotypic profile of fibroblasts derived from induced pluripotent stem cells. PLoS One 6:e17128
Shamis, Yulia; Hewitt, Kyle J; Carlson, Mark W et al. (2011) Fibroblasts derived from human embryonic stem cells direct development and repair of 3D human skin equivalents. Stem Cell Res Ther 2:10
Egles, Christophe; Garlick, Jonathan A; Shamis, Yulia (2010) Three-dimensional human tissue models of wounded skin. Methods Mol Biol 585:345-59
Etienne, Olivier; Schneider, Aurore; Kluge, Jonathan A et al. (2009) Soft tissue augmentation using silk gels: an in vitro and in vivo study. J Periodontol 80:1852-8

Showing the most recent 10 out of 16 publications